Evidence map›Paper›PMID 35419331›Full record

ArticleFrontiers in public health2022

Gut Bacteria

Shang Cai, Yongqiang Yang, Yuehong Kong, Qi Guo, Yingying Xu, Pengfei Xing, Yanze Sun, Jianjun Qian, Ruizhe Xu, Liwei Xie and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. A phase II clinical trial ofFrontiers in nutrition · 2025
    Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Luohuazizhu Granules Alleviate Symptoms of Ulcerative ColitisCombinatorial chemistry & high throughput screening · 2026
    Article
  9. Article
  10. Targeting gut microbiota and metabolites in cancer radiotherapy.Clinical and translational medicine · 2025
    Review
  11. Article
  12. Article
  13. Observational
  14. [Rifaximin curative effect and mechanism on monocrotaline-induced hepatic sinusoidal obstruction syndrome in mice].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  15. Article
  16. Frontiers in pharmacology · 2025
    Article
  17. Review
  18. Article
  19. Antioxidants (Basel, Switzerland) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Shang CaiDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yongqiang YangDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yuehong KongDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Qi GuoDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yingying XuDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Pengfei XingDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yanze SunDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Jianjun QianDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Ruizhe XuDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Liwei XieDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yijia HuDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Min WangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Ming LiState Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, China.
Ye TianDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Weidong MaoDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Soochow University · CNSecond Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is difficult to study the intestinal damage induced by space radiation to astronauts directly, and few prediction models exist. However, we can simulate it in patients with pelvic tumor radiotherapy (RT). Radiation-induced intestinal injury (RIII) is common in cancer patients who receieved pelvic and abdominal RT. We dynamically analyzed gut microbiota and metabolites alterations in 17 cervical and endometrial cancer patients after pelvic RT. In patients who later developed grade 2 RIII, dysbiosis of gut microbiota and metabolites were observed. Univariate analysis showed that

Indexed as

Gastrointestinal MicrobiomeRadiation InjuriesBacteriaDysbiosisHumansPregnanesPregnanesptilosteroid Abiomarkergut bacteriagut bacteria related metaboliteradiation-induced intestinal injuryradiotherapy

Identifiers

PMID35419331
PMCPMC8995795
OpenAlexW4221089172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.